These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. Carlson PE; Walk ST; Bourgis AE; Liu MW; Kopliku F; Lo E; Young VB; Aronoff DM; Hanna PC Anaerobe; 2013 Dec; 24():109-16. PubMed ID: 23608205 [TBL] [Abstract][Full Text] [Related]
29. Epidemiologic trends in Clostridioides difficile isolate ribotypes in United States from 2011 to 2016. Snydman DR; McDermott LA; Jenkins SG; Goldstein EJC; Patel R; Forbes BA; Johnson S; Gerding DN; Thorpe CM; Walk ST Anaerobe; 2020 Jun; 63():102185. PubMed ID: 32387171 [TBL] [Abstract][Full Text] [Related]
30. Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile. Fawley WN; Knetsch CW; MacCannell DR; Harmanus C; Du T; Mulvey MR; Paulick A; Anderson L; Kuijper EJ; Wilcox MH PLoS One; 2015; 10(2):e0118150. PubMed ID: 25679978 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology. Martinson JN; Broadaway S; Lohman E; Johnson C; Alam MJ; Khaleduzzaman M; Garey KW; Schlackman J; Young VB; Santhosh K; Rao K; Lyons RH; Walk ST J Clin Microbiol; 2015 Apr; 53(4):1192-7. PubMed ID: 25631804 [TBL] [Abstract][Full Text] [Related]
32. Two-year analysis of Clostridium difficile ribotypes associated with increased severity. Herbert R; Hatcher J; Jauneikaite E; Gharbi M; d'Arc S; Obaray N; Rickards T; Rebec M; Blandy O; Hope R; Thomas A; Bamford K; Jepson A; Sriskandan S J Hosp Infect; 2019 Dec; 103(4):388-394. PubMed ID: 31220480 [TBL] [Abstract][Full Text] [Related]
33. C. difficile ribotype 027 or 176? Krutova M; Matejkova J; Nyc O Folia Microbiol (Praha); 2014 Nov; 59(6):523-6. PubMed ID: 24970104 [TBL] [Abstract][Full Text] [Related]
34. An Observational Cohort Study of Rao K; Higgins PDR; Young VB mSphere; 2018; 3(3):. PubMed ID: 29794054 [TBL] [Abstract][Full Text] [Related]
35. Prevalence, toxin gene profile, genotypes and antibiotic susceptibility of Saber T; Hawash YA; Ismail KA; Khalifa AS; Alsharif KF; Alghamdi SA; Saber T; Eed EM Indian J Med Microbiol; 2020; 38(2):176-182. PubMed ID: 32883931 [TBL] [Abstract][Full Text] [Related]
36. Genetic diversity and phylogenetic analysis of the surface layer protein A gene (slpA) among Clostridioides difficile clinical isolates from Tehran, Iran. Noori M; Ghalavand Z; Azimirad M; Yadegar A; Eslami G; Krutova M; Brajerova M; Goudarzi M; Zali MR Anaerobe; 2021 Aug; 70():102403. PubMed ID: 34111549 [TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile infection: monoclonal or polyclonal genesis? Hell M; Permoser M; Chmelizek G; Kern JM; Maass M; Huhulescu S; Indra A; Allerberger F Infection; 2011 Oct; 39(5):461-5. PubMed ID: 21826436 [TBL] [Abstract][Full Text] [Related]
38. First genotypic characterization of toxigenic Clostridioides difficile in Lithuanian hospitals reveals the prevalence of the hypervirulent ribotype 027/ST1. Tratulyte S; Miciuleviciene J; Kuisiene N Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1953-1959. PubMed ID: 31327067 [TBL] [Abstract][Full Text] [Related]
39. Use of single molecule sequencing for comparative genomics of an environmental and a clinical isolate of Clostridium difficile ribotype 078. Hargreaves KR; Thanki AM; Jose BR; Oggioni MR; Clokie MR BMC Genomics; 2016 Dec; 17(1):1020. PubMed ID: 27964731 [TBL] [Abstract][Full Text] [Related]
40. Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping. Behroozian AA; Chludzinski JP; Lo ES; Ewing SA; Waslawski S; Newton DW; Young VB; Aronoff DM; Walk ST Infect Control Hosp Epidemiol; 2013 Sep; 34(9):961-966. PubMed ID: 23917911 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]